Making OraQuick quicker: The VIRCAN 5-Minute Rule
What do online users want from HIV/STI risk calculators?
Four questions with the Manitoba HIV/STBBI Collective Impact Network
More
Long-acting injectable drug prevents HIV
Call for Nominations to the Board of Directors Deadline: July 26, 2020
The promise of remdesivir for COVID-19
Health Canada issues an alert about chloroquine and hydroxychloroquine
Case series of HIV and COVID-19 in Spain
Kaletra disappointing in people severely ill with COVID-19
Coronavirus disease (COVID-19), HIV and hepatitis C: What you need to know
CATIE update on COVID-19
Coronavirus disease (COVID-19): Outbreak update
Canadian trends in hepatitis C virus treatment for people co-infected with HCV and HIV
Might cost issues affect the success of HIV care programs in the future?
Improved health when treatment for both hepatitis C and opioid use disorder are offered
Amenorrhea linked to bone loss in HIV-positive women
Traditional risk factors have a big impact on bone thinning in HIV-positive people
Managing medicines may become more difficult as some HIV-positive people age
High interest in syphilis pre- and post-exposure prophylaxis (PrEP and PEP) among men who have sex with men
Assessing the cascade of care for opioid use disorder in British Columbia
Montreal doctors report on cases of syphilis affecting the eyes
High rates of frailty seen among middle-aged and older HIV-positive people in Alberta
Can mirtazapine help treat crystal meth dependency?
Can vitamin E help fight fatty liver disease in HIV-positive people?
Changes in CD4+ cell count after cancer treatment linked to survival among HIV-positive people
Factors associated with hepatitis C infection among men who take PrEP
Problems with movement and muscle coordination found in some HIV-positive people
Exploring the impact of aging on the brains of HIV-positive and HIV-negative people
CATIE’s bite sized HIV and hepatitis C news bulletins
CATIE’s flagship digest on cutting-edge developments in HIV and hepatitis C research and treatment.
CATIE’s spotlight on HIV and hepatitis C programs and research.